Cassella AG Report issue

For profit Phase 3 Phase 4
Founded: Frankfurt Germany (1798)
Status: Defunct (1995)

Organization Overview

First Clinical Trial
2002
NCT00861978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Cassella Farbwerke Mainkur | Cassella-med GmbH & Co. KG | Cassel & Reiss

Active Ingredients

Drugs in Phase 4 Trials (1)

peppermint extract (1 trial)

Drugs in Phase 3 Trials (1)

hypericum perforatum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Depressive Disorder (Phase 3)

Headache (Phase 4)

Tension-Type Headache (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2